Evidence map›Paper›PMID 40830145›Full record

ArticleScientific reports2025

Predictive modeling of asthma drug properties using machine learning and topological indices in a MATLAB based QSPR study.

Jalal Hatem Hussein Bayati, Abid Mahboob, Laiba Amin, Muhammad Waheed Rasheed, Abdu Alameri

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jalal Hatem Hussein BayatiDepartment of Mathematics, College of Science for Woman, University of Baghdad, Baghdad, Iraq.
Abid MahboobDepartment of Mathematics, Division of Science and Technology, University of Education, Lahore, Pakistan.
Laiba AminDepartment of Mathematics, COMSATS University Islamabad, Vehari Campus, Vehari, 61100, Pakistan.
Muhammad Waheed RasheedDepartment of Mathematics, COMSATS University Islamabad, Vehari Campus, Vehari, 61100, Pakistan.
Abdu AlameriDepartment of Biomedical Engineering, University of Science and Technology, Yemen, Sana'a, Yemen. a.alameri2222@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machine learning is a vital tool in advancing drug development by accurately predicting the physical, chemical, and biological properties of various compounds. This study utilizes MATLAB program-based algorithms to calculate topological indices and machine learning algorithms to explore their ability to predict the physio-chemical properties of asthma drugs. By combining machine learning with topological indices, we can conduct faster and more precise analyses of drug structures. As we deepen our understanding of the relationship between molecular structure and performance, the integration of machine learning with QSPR research highlights the significant potential of computational strategies in pharmaceutical discovery. The use of machine learning algorithms such as random forest and extreme gradient boosting is essential in this process. These algorithms leverage labeled data to predict complex molecular processes, aiding in the discovery of new medication options and enhancing their properties. These methods enhance the accuracy of physical and chemical property predictions, streamline the drug discovery process, and efficiently evaluate large datasets through machine learning. Ultimately, these advancements facilitate the development of innovative and effective treatments.

Indexed as

Anti-Asthmatic AgentsAsthmaMachine LearningQuantitative Structure-Activity RelationshipAlgorithmsDrug DiscoveryHumansAnti-Asthmatic AgentsAsthma drugsExtreme gradient boostingMachine learningMATLAB and Python algorithmRandom forestReducible topological descriptors

Identifiers

PMID40830145
PMCPMC12365144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.